These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25425654)

  • 21. Functional interaction of tumor suppressor DLC1 and caveolin-1 in cancer cells.
    Du X; Qian X; Papageorge A; Schetter AJ; Vass WC; Liu X; Braverman R; Robles AI; Lowy DR
    Cancer Res; 2012 Sep; 72(17):4405-16. PubMed ID: 22693251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restoration of DLC1 gene inhibits proliferation and migration of human colon cancer HT29 cells.
    Wu PP; Jin YL; Shang YF; Jin Z; Wu P; Huang PL
    Ann Clin Lab Sci; 2009; 39(3):263-9. PubMed ID: 19667410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRL4A-FBXW5-mediated degradation of DLC1 Rho GTPase-activating protein tumor suppressor promotes non-small cell lung cancer cell growth.
    Kim TY; Jackson S; Xiong Y; Whitsett TG; Lobello JR; Weiss GJ; Tran NL; Bang YJ; Der CJ
    Proc Natl Acad Sci U S A; 2013 Oct; 110(42):16868-73. PubMed ID: 24082123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The intracellular stability of DLC1 is regulated by the 26S proteasome in human hepatocellular carcinoma cell line Hep3B.
    Luo HW; Luo QP; Yuan Y; Zhu XY; Huang SF; Peng Z; Li CL; Huang ZG; Feng WL
    Biochem Biophys Res Commun; 2011 Jan; 404(1):279-83. PubMed ID: 21130076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor suppressor gene DLC1: Its modifications, interactive molecules, and potential prospects for clinical cancer application.
    Ren G; Li G
    Int J Biol Macromol; 2021 Jul; 182():264-275. PubMed ID: 33836193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deleted in liver cancer 1 isoforms are distinctly expressed in human tissues, functionally different and under differential transcriptional regulation in hepatocellular carcinoma.
    Ko FC; Yeung YS; Wong CM; Chan LK; Poon RT; Ng IO; Yam JW
    Liver Int; 2010 Jan; 30(1):139-48. PubMed ID: 19874489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DLC1 is the principal biologically-relevant down-regulated DLC family member in several cancers.
    Wang D; Qian X; Rajaram M; Durkin ME; Lowy DR
    Oncotarget; 2016 Jul; 7(29):45144-45157. PubMed ID: 27174913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and characterization of Dlc1 isoforms in the mouse and study of the biological function of a single gene trapped isoform.
    Sabbir MG; Wigle N; Loewen S; Gu Y; Buse C; Hicks GG; Mowat MR
    BMC Biol; 2010 Mar; 8():17. PubMed ID: 20199662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CDK5 is a major regulator of the tumor suppressor DLC1.
    Tripathi BK; Qian X; Mertins P; Wang D; Papageorge AG; Carr SA; Lowy DR
    J Cell Biol; 2014 Dec; 207(5):627-42. PubMed ID: 25452387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deleted in liver cancer-1 (DLC1): an emerging metastasis suppressor gene.
    Popescu NC; Goodison S
    Mol Diagn Ther; 2014 Jun; 18(3):293-302. PubMed ID: 24519699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A tumor suppressor DLC1: The functions and signal pathways.
    Zhang Y; Li G
    J Cell Physiol; 2020 Jun; 235(6):4999-5007. PubMed ID: 31773748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequent Downregulation and Promoter Hypermethylation of DLC1: Relationship with Clinical Outcome in Gallbladder Cancer.
    Singh D; Bharti A; Biswas D; Tewari M; Kar AG; Ansari MA; Singh S; Narayan G
    J Gastrointest Cancer; 2022 Jun; 53(2):237-244. PubMed ID: 33417200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear DLC1 exerts oncogenic function through association with FOXK1 for cooperative activation of MMP9 expression in melanoma.
    Yang X; Hu F; Liu JA; Yu S; Cheung MPL; Liu X; Ng IO; Guan XY; Wong KKW; Sharma R; Lung HL; Jiao Y; Lee LTO; Cheung M
    Oncogene; 2020 May; 39(20):4061-4076. PubMed ID: 32214200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SRC and ERK cooperatively phosphorylate DLC1 and attenuate its Rho-GAP and tumor suppressor functions.
    Tripathi BK; Anderman MF; Qian X; Zhou M; Wang D; Papageorge AG; Lowy DR
    J Cell Biol; 2019 Sep; 218(9):3060-3076. PubMed ID: 31308216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of deleted in liver cancer 1 tumor suppressor by protein-protein interactions and phosphorylation.
    Ko FC; Ping Yam JW
    Int J Cancer; 2014 Jul; 135(2):264-9. PubMed ID: 24114040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
    Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
    Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DLC1 is unlikely to be a primary target for deletions on chromosome arm 8p22 in head and neck squamous cell carcinoma.
    Hewitt C; Wilson P; McGlinn E; MacFarlane G; Papageorgiou A; Woodwards RT; Sloan P; Gollin SM; Paterson I; Parkinson KK; Read AP; Thakker N
    Cancer Lett; 2004 Jun; 209(2):207-13. PubMed ID: 15159023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.
    Wong CM; Yam JW; Ching YP; Yau TO; Leung TH; Jin DY; Ng IO
    Cancer Res; 2005 Oct; 65(19):8861-8. PubMed ID: 16204057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluctuation of ROS regulates proliferation and mediates inhibition of migration by reducing the interaction between DLC1 and CAV-1 in breast cancer cells.
    Yang B; Zhu W; Zheng Z; Chai R; Ji S; Ren G; Liu T; Liu Z; Song T; Li F; Liu S; Li G
    In Vitro Cell Dev Biol Anim; 2017 Apr; 53(4):354-362. PubMed ID: 28130753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of DLC1 as a prostate cancer susceptibility gene: mutation screen and association study.
    Zheng SL; Mychaleckyj JC; Hawkins GA; Isaacs SD; Wiley KE; Turner A; Chang BL; von Kap-Herr C; Carpten JD; Pettenati M; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB; Xu J
    Mutat Res; 2003 Jul; 528(1-2):45-53. PubMed ID: 12873722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.